- Advertisement -

New compound prevents amyloid formation to fight Alzheimer’s disease

It is known that Alzheimer’s disease is caused by the formation of amyloid plaques and tau tangles in the brain. A novel compound shows...

Biotechnology Industry Gets A Boost From Community College Degrees – Forbes

Pictured: Dolores Grijalva a student in MiraCosta College's Biomanufacturing Bachelor's Degree ... program, the first bachelor's degree of its kind at a community...

The path to a better tuberculosis vaccine runs through Montana

A team of Montana researchers is playing a key role in the development of a more effective vaccine against tuberculosis, an infectious disease that...

Terumo BCT and Nova Biomedical Collaborate on Automated Cell Culture Sensing

Terumo Blood and Cell Technologies (Terumo BCT) agreed to collaborate with Nova Biomedical to enable automated cell culture sensing with Terumo BCT’s Quantum Flex...

New reference database Greengenes2 improves reproducibility of microbiome studies

Two leading sequencing techniques are no longer at odds, thanks to an international effort led by scientists at University of California San Diego. In...

Protein Protects Against Tau Tangles, Synaptic Loss in Mouse Model of...

Alzheimer’s disease (AD) and many other forms of neurodegeneration share a common culprit. In these diseases, tau proteins that normally stabilize neuronal microtubule filaments...

Axiom’s Hong Kong Bet, Latigo’s Positive Phase II, and Base Editors...

In the business news section of this week’s episode, Axiom Biosciences recently announced its plans to go public and made headlines for its plans...

Elix and University of Vienna Aim to Advance Drug Discovery Using...

Tokyo-based Elix and the University of Vienna signed a joint research agreement aimed at advancing drug discovery using AI technologies. One of Elix’s business models...

Axiom’s Hong Kong Bet, Latigo’s Positive Phase II, and Base Editors for Huntington’s

In the business news section of this week’s episode, Axiom Biosciences recently announced its plans to go public and made headlines for its plans...

Elix and University of Vienna Aim to Advance Drug Discovery Using AI

Tokyo-based Elix and the University of Vienna signed a joint research agreement aimed at advancing drug discovery using AI technologies. One of Elix’s business models...

Base Editing Strategy Alleviates Huntington’s Disease in Mice

According to at least one estimate, approximately 41,000 people in the United States have symptoms of Huntington’s disease, and more than 200,000 are at-risk...

more new items

Axiom’s Hong Kong Bet, Latigo’s Positive Phase II, and Base Editors...

In the business news section of this week’s episode, Axiom Biosciences recently announced its plans to go public and made headlines for its plans...

Elix and University of Vienna Aim to Advance Drug Discovery Using...

Tokyo-based Elix and the University of Vienna signed a joint research agreement aimed at advancing drug discovery using AI technologies. One of Elix’s business models...

Base Editing Strategy Alleviates Huntington’s Disease in Mice

According to at least one estimate, approximately 41,000 people in the United States have symptoms of Huntington’s disease, and more than 200,000 are at-risk...